NCT06130566 · Interventional trial
A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis
Overall registry status Completed
Phase 3
Conditions Dermatitis Atopic
Delaware Valley sites
- Clinical Research of Philadelphia- Site Number : 8401193 · Philadelphia, PA · Philadelphia County
- Paddington Testing Company- Site Number : 8401041 · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory